Not everyone is sold on the benefits of early ezetimibe use, especially given the modest effect seen in IMPROVE-IT.

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

This month: shorter recovery after TAVI, Down syndrome CV insights, the benefits of brisker walking, and more.

For all the different subpopulations, having a CAC score > 100 strongly predicted risk of CV death (P < 0.007). Yet the ...

Once-daily orforglipron was more effective than placebo and just as safe as injectable GLP-1s in patients with diabetes and ...

Numerous components beyond length of sleep have important ties to cardiometabolic disease and related risk factors.

Added information from the assays could guide care, especially for intermediate-risk patients on the cusp of initiating ...

Sunil Rao and Michelle O'Donoghue delve into the details.

Juan Granada, MD, and Brian Lindman, MD, share insights on tools and data that can be used to ahieve earlier diagnosis and ...

In patients with gastrointestinal cancers treated with fluoropyrimidine-based chemotherapy agents, better overall survival at 1 year offsets a small increase in their risk of CV events, new data ...